A Review on Tablet Scoring: Background, History and Current Regulatory Considerations
Journal Title: Journal of Pharmaceutical Research International - Year 2017, Vol 20, Issue 5
Abstract
Tablet splitting or breaking of tablets into multiple strengths has been a common practice across the world. Splitting of tablet offers various advantages such as dose flexibility and ease of swallowing in different population including geriatric and pediatric patients (wide patient acceptance) and cost saving on medications (economic advantage) The tablet products that are meant to be split and approved by the Food and Drug Administration (FDA) will have a scored line indicating the split location to ensure patient can adjust the dose by splitting and such splitting information will be included in the patient package insert. Having a consistent scored reduces difficulty in dose related problems especially when using products made by different manufacturers such as Generic compared to Reference Listed Drugs (RLD). Physical characteristics such as shape, size and tablet score may affect tablet splitability. Currently, various regulatory bodies (FDA, USP, and EP) provide consistent and useful information to the pharmaceutical industry. In this review, authors have compiled information from currently available resources on tablet scoring.
Authors and Affiliations
Maitri R. Trivedi, Hardikkumar H. Patel, Rutesh H. Dave
Keywords
Related Articles
- EP ID EP313157
- DOI 10.9734/JPRI/2017/39027
- Views 105
- Downloads 0
A Study of the Antimicrobial Effectiveness of Diluted Antiseptics in Nigeria
Aim: The antimicrobial effectiveness of diluted antiseptics and the health risks that may be associated with any surviving pathogens were investigated. Study Design: Experimental Study. Place and Duration of Study: Facu...
Performance of Meloxicam Niosomal Gel Formulations for Transdermal Drug Delivery
Niosomes have been reported as a possible approach to improve low skin permeation shown by conventional vehicles. In this study, a noisome-based delivery system of meloxicam (MX) was developed and characterized for in vi...
HPLC, Densitometric and Visible-Spectrophotometric Determination of Triclabendazole and Ivermectin
Two methods were developed for simultaneous determination of triclabendazole and ivermectin, in addition to a Vis-spectrophotometric method for the analysis of ivermectin only. The first one was HPLC method in which effi...
Clinical Outcome Evaluation of Glycaemic Control in a Metformin-based Therapy of Type 2 Diabetes Mellitus Patients Managed Under Ambulatory Care Settings
Background: Short term clinical outcomes evaluation of glycaemic goals or its control are desirable to monitor response to therapy in individual patients and to identify compliance or other problem areas. Aim and Objecti...
The Utilization Pattern and Costs Analysis of Psychotropic Drugs at a Neuropsychiatric Hospital in Nigeria
Background/Aim: Drug utilisation study is essential for evaluating patient care to improve service delivery through awareness creation for appropriate choice of drugs. The study analysed the prescription pattern and asso...